CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 31 filers reported holding CHEMBIO DIAGNOSTICS INC in Q1 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $6,441 | -19.5% | 29,315 | +35.2% | 0.00% | – |
| Q3 2022 | $8,000 | -33.3% | 21,687 | +13.6% | 0.00% | – |
| Q2 2022 | $12,000 | -33.3% | 19,093 | -12.9% | 0.00% | – |
| Q1 2022 | $18,000 | -28.0% | 21,917 | +0.5% | 0.00% | – |
| Q4 2021 | $25,000 | -85.9% | 21,817 | -69.1% | 0.00% | – |
| Q3 2021 | $177,000 | +742.9% | 70,601 | +1069.5% | 0.00% | – |
| Q1 2021 | $21,000 | -89.9% | 6,037 | -86.2% | 0.00% | – |
| Q4 2020 | $208,000 | +105.9% | 43,888 | +110.3% | 0.00% | – |
| Q3 2020 | $101,000 | -6.5% | 20,868 | -36.9% | 0.00% | – |
| Q2 2020 | $108,000 | – | 33,086 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 1,721,299 | $10,672,000 | 1.91% |
| ARS Investment Partners, LLC | 785,343 | $4,869,000 | 0.63% |
| PERKINS CAPITAL MANAGEMENT INC | 35,500 | $220,000 | 0.23% |
| Benchmark Capital Advisors | 32,900 | $204,000 | 0.16% |
| FNY Managed Accounts LLC | 2,784 | $17,000 | 0.02% |
| THOMPSON DAVIS & CO., INC. | 1,500 | $9,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 80,100 | $497,000 | 0.01% |
| WELLINGTON MANAGEMENT GROUP LLP | 918,535 | $5,695,000 | 0.00% |
| ROYCE & ASSOCIATES LP | 21,900 | $136,000 | 0.00% |
| Phocas Financial Corp. | 20,000 | $0 | 0.00% |